Tregs expanded in vivo by TNFRSF25 agonists promote cardiac allograft survival

Transplantation

Volumn 94, Issue 6, 2012, Pages 569-574

  Wolf, Dietlinde ^a   Schreiber, Taylor H ^a   Tryphonopoulos, Panagiotis ^a   Li, Sen ^a   Tzakis, Andreas G ^a   Ruiz, Phillip ^a   Podack, Eckhard R ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Immune rejection; TL1A TNFSF15; TNFRSF25; Transplantation tolerance; Treg to Teff ratio

Indexed keywords

4C12; CD4 ANTIGEN; CYTOKINE RECEPTOR AGONIST; DEATH RECEPTOR 3; DEATH RECEPTOR 3 AGONIST; MAJOR HISTOCOMPATIBILITY ANTIGEN; REGULATOR PROTEIN; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIAC GRAFT REJECTION; CD4+ T LYMPHOCYTE; CELL EXPANSION; CELL INFILTRATION; CONTROLLED STUDY; DISEASE SEVERITY; FLOW CYTOMETRY; GRAFT SURVIVAL; HEART BEAT; HEART CONTRACTION; HEART TRANSPLANTATION; HISTOPATHOLOGY; IN VIVO STUDY; INFLAMMATORY CELL; MALE; MOUSE; NONHUMAN; PALPATION; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY T LYMPHOCYTE;

ANIMALS; ANTIBODIES; BIOLOGICAL MARKERS; CELL PROLIFERATION; CYTOKINES; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; HISTOCOMPATIBILITY; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED CBA; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, TUMOR NECROSIS FACTOR, MEMBER 25; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTES, REGULATORY; TIME FACTORS;

EID: 84866731302     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318264d3ef     Document Type: Article

References (40)

1. Nicholson V, Johnson PC. Infectious complications in solid organ transplant recipients. Surg Clin North Am 1994; 74: 122-3.
2. Gutierrez-Dalmau A, Campistol JM. Immunosuppressive therapy and malignancy in organ transplant recipients: a systematic review. Drugs 2007; 67: 116-7.
3. Ojo AO, Held PJ, Port FK, et al. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 2003; 349: 93-1.
4. Wood KJ, Sakaguchi S. Regulatory T cells in transplantation tolerance. Nat Rev Immunol 2003; 3: 19-9.
5. Battaglia M. Potential T regulatory cell therapy in transplantation: how far have we come and how far can we go? Transpl Int 2011; 23: 76-1.
6. Fan H, Cao P, Game DS, et al. Regulatory T cell therapy for the induction of clinical organ transplantation tolerance. Semin Immunol 2011; 23: 45-3.
7. Hippen KL, Riley JL, June CH, et al. Clinical perspectives for regulatory T cells in transplantation tolerance. Semin Immunol 2011; 23: 46-2.
8. Benghiat FS, Graca L, Braun MY, et al. Critical influence of natural regulatory CD25+ T cells on the fate of allografts in the absence of immunosuppression. Transplantation 2005; 79: 64-8.
9. Francis RS, Feng G, Tha-In T, et al. Induction of transplantation tolerance converts potential effector T cells into graft-protective regulatory T cells. Eur J Immunol 2011; 41: 72-6.
10. Kendal AR, Chen Y, Regateiro FS, et al. Sustained suppression by Foxp3+ regulatory T cells is vital for infectious transplantation tolerance. J Exp Med 2011; 208: 204-3.
11. Shan J, Guo Y, Luo L, et al. Do CD4+ Foxp3+ Treg cells correlate with transplant outcomes: a systematic review on recipients of solid organ transplantation. Cell Immunol 2011; 270: -5.
12. Fang L, Adkins B, Deyev V, et al. Essential role of TNF receptor superfamily 25 (TNFRSF25) in the development of allergic lung inflammation. J ExpMed 2008; 205: 103-7.
13. Schreiber TH, Wolf D, Tsai MS, et al. Therapeutic Treg expansion in mice by TNFRSF25 prevents allergic lung inflammation. J Clin Invest 2010; 120: 362-9.
14. Meylan F, Richard AC, Siegel RM. TL1A and DR3, a TNF family ligandreceptor pair that promotes lymphocyte costimulation, mucosal hyperplasia, and autoimmune inflammation. Immunol Rev 2011; 244: 18-8.
15. Bestard O, Cruzado JM, Rama I, et al. Presence of FoxP3+ regulatory T Cells predicts outcome of subclinical rejection of renal allografts. J Am Soc Nephrol 2008; 19: 202-0.
16. Koizumi H, Konoeda Y, Kobayashi S, et al. Comparison of methods to evaluate acute rejection in heterotopic heart transplantation in rats. Exp Anim 1996; 45: 21-7.
17. Banerjee I, Fuseler JW, Price RL, et al. Determination of cell types and numbers during cardiac development in the neonatal and adult rat and mouse. Am J Physiol Heart Circ Physiol 2007; 293: H188-3.
18. Lee I,Wang L,Wells AD, et al. Recruitment of Foxp3+ T regulatory cells mediating allograft tolerance depends on the CCR4 chemokine receptor. J Exp Med 2005; 201: 103-7.
19. Munn DH. Indoleamine 2,3-dioxygenase, Tregs and cancer. Curr Med Chem 2011; 18: 224-0.
20. Munn DH, Zhou M, Attwood JT, et al. Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 1998; 281: 119-1.
21. YuG, DaiH, Chen J, et al.Gene delivery of indoleamine 2,3-dioxygenase prolongs cardiac allograft survival by shaping the types of T-cell responses. J Gene Med 2008; 10: 75-4.
22. Li J,MeinhardtA, RoehrichME, et al. Indoleamine 2,3-dioxygenase gene transfer prolongs cardiac allograft survival. Am J Physiol Heart Circ Physiol 2007; 293: H341-5.
23. Heidt S, Segundo DS, Chadha R, et al. The impact of Th17 cells on transplant rejection and the induction of tolerance. Curr Opin Organ Transplant 2010; 15: 45-6.
24. Cunnusamy K, Chen PW, Niederkorn JY. IL-17AYdependent CD4+ CD25+ regulatory T cells promote immune privilege of corneal allografts. J Immunol 2011; 186: 673-7.
25. Itoh S, Kimura N, Axtell RC, et al. Interleukin-17 accelerates allograft rejection by suppressing regulatory T cell expansion. Circulation 2011; 124(11 suppl): S18-7.
26. Choy JC. Granzymes and perforin in solid organ transplant rejection. Cell Death Differ 2010; 17: 56-7.
27. Sagoo P, Ali N, Garg G, et al. Human regulatory T cells with alloantigen specificity are more potent inhibitors of alloimmune skin graft damage than polyclonal regulatory T cells. Sci Transl Med 2011; 3: 83ra4-2.
28. Fan Z, Spencer JA, Lu Y, et al. In vivo tracking of 'color-coded' effector, natural and induced regulatory T cells in the allograft response. NatMed 2010; 16: 71-8.
29. Taylor PA, Lees CJ, Blazar BR. The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graftversus-host disease lethality. Blood 2002; 99: 349-3.
30. Jiang S, Tsang J, Game DS, et al. Generation and expansion of human CD4+ CD25+ regulatory T cells with indirect allospecificity: Potential reagents to promote donor-specific transplantation tolerance. Transplantation 2006; 82: 173-8.
31. Issa F, Hester J, Goto R, et al. Ex vivoYexpanded human regulatory T cells prevent the rejection of skin allografts in a humanized mouse model. Transplantation 2010; 90: 132-1.
32. Hippen KL, Merkel SC, Schirm DK, et al. Generation and large-scale expansion of human inducible regulatory T cells that suppress graftversus-host disease. Am J Transplant 2011; 11: 114-8.
33. Brunstein CG, Miller JS, Cao Q, et al. Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics. Blood 2011; 117: 106-1.
34. Roncarolo MG, Gregori S, Lucarelli B, et al. Clinical tolerance in allogeneic hematopoietic stem cell transplantation. Immunol Rev 2011; 241: 14-5.
35. Boyman O, Kovar M, Rubinstein MP, et al. Selective stimulation of T cell subsets with antibody-cytokine immune complexes. Science 2006; 311: 192-4.
36. Pacholczyk R, Kern J, Singh N, et al. Nonself-Antigens are the cognate specificities of Foxp3+ regulatory T cells. Immunity 2007; 27: 49-3.
37. Moon JJ, Dash P, Oguin TH 3rd, et al. Quantitative impact of thymic selection on Foxp3+ and Foxp3j subsets of self-peptide/MHC class IIYspecific CD4+ T cells. Proc Natl Acad Sci U S A 2011; 108: 1460-2.
38. Niimi M. The technique for heterotopic cardiac transplantation in mice: experience of 3000 operations by one surgeon. J Heart Lung Transplant 2001; 20: 112-3.
39. Stewart S, Winters GL, Fishbein MC, et al. Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant 2005; 24: 171-0.
40. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-Time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001; 25: 40-2.